IL15 and neoplasm: Consistent with the flow cytometry and immunofluorescence findings, we observed both tumor clusters and NK clusters as the major populations (57% NK cells versus 43% tumor cells) in the MSLN.CAR-IL-15 GR1.1-iNK–treated tumors as compared to the untreated tumors (Fig. 7C).